State of Wisconsin Investment Board
CRSP icon

State of Wisconsin Investment Board’s CRISPR Therapeutics CRSP Stock Holding History

State of Wisconsin Investment Board’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Sell
51,128
-1,418
-3% -$74.7K 0.01% 1350
2026
Q1 		$2.5M Buy
52,546
+4,374
+9% +$231K 0.01% 1318
2025
Q4 		$2.53M Sell
48,172
-3,495
-7% -$209K 0.01% 1328
2025
Q3 		$3.35M Buy
51,667
+102
+0.2% +$5.86K 0.01% 1117
2025
Q2 		$2.51M Sell
51,565
-785
-1% -$30.4K 0.01% 1190
2025
Q1 		$1.78M Buy
52,350
+29
+0.1% +$1.23K ﹤0.01% 1287
2024
Q4 		$2.06M Sell
52,321
-1,668
-3% -$78.8K 0.01% 1276
2024
Q3 		$2.54M Sell
53,989
-1,282
-2% -$65K 0.01% 1217
2024
Q2 		$2.99M Buy
55,271
+550
+1% +$31.8K 0.01% 1133
2024
Q1 		$3.73M Sell
54,721
-7,003
-11% -$501K 0.01% 1048
2023
Q4 		$3.86M Sell
61,724
-1,162
-2% -$64.2K 0.01% 1070
2023
Q3 		$2.85M Sell
62,886
-2,254
-3% -$116K 0.01% 1146
2023
Q2 		$3.66M Sell
65,140
-3,466
-5% -$197K 0.01% 1107
2023
Q1 		$3.1M Sell
68,606
-5,734
-8% -$278K 0.01% 1164
2022
Q4 		$3.02M Sell
74,340
-598
-0.8% -$31.7K 0.01% 1187
2022
Q3 		$4.9M Sell
74,938
-3,707
-5% -$269K 0.02% 957
2022
Q2 		$4.78M Buy
78,645
+27,845
+55% +$1.64M 0.01% 1017
2022
Q1 		$3.19M Buy
+50,800
New +$3.19M 0.01% 1337
2021
Q4 		– Sell
-22,961
Closed -$2.57M – 2167
2021
Q3 		$2.57M Buy
+22,961
New +$2.88M 0.01% 1230

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State of Wisconsin Investment Board's CRSP Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its CRISPR Therapeutics (CRSP) stake by 2.7% in Q2 2026, selling an estimated $74.7K and leaving 51,128 shares worth $2.79M. The position accounts for 0.01% of the portfolio, ranked #1350.

State of Wisconsin Investment Board first reported a position in CRSP in Q3 2021 and has held it in 19 quarters since. The position peaked at $4.9M in Q3 2022. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • State of Wisconsin Investment Board held 51,128 shares of CRISPR Therapeutics worth $2.79M as of Q2 2026.
  • State of Wisconsin Investment Board sold 1,418 CRISPR Therapeutics shares in Q2 2026, an estimated $74.7K.
  • CRISPR Therapeutics made up 0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1350 holding.
  • State of Wisconsin Investment Board first reported a position in CRISPR Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • State of Wisconsin Investment Board's CRISPR Therapeutics position peaked at $4.9M in Q3 2022.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.